This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Biotech

Why Novartis AG (NVS) Stock Is Climbing Today

Why Novartis AG (NVS) Stock Is Climbing Today

  • Tickers in this article:
  • NVS

Novartis AG (NVS) shares are higher after the company reported positive results from its heart failure prevention drug treatment study.

09/02/14 - 10:19 AM EDT

Regeneron Shares Trend Higher on Cholesterol-Lowering Results

  • Tickers in this article:
  • SNY
  • REGN

Shares of Regeneron and Sanofi are opening the week higher after revealing an experimental cholesterol-lowering drug nearly halved the number of heart attacks and strokes in a clinical trial.

09/02/14 - 09:53 AM EDT

Why Novartis AG (NVS) Stock Is Climbing Today

Why Novartis AG (NVS) Stock Is Climbing Today

  • Tickers in this article:
  • NVS

Novartis AG (NVS) shares are higher after the company reported positive results from its heart failure prevention drug treatment study.

09/02/14 - 10:19 AM EDT

Regeneron Shares Trend Higher on Cholesterol-Lowering Results

  • Tickers in this article:
  • SNY
  • REGN

Shares of Regeneron and Sanofi are opening the week higher after revealing an experimental cholesterol-lowering drug nearly halved the number of heart attacks and strokes in a clinical trial.

09/02/14 - 09:53 AM EDT

‘Breaking Bad’ Wins Big, Amazon Taps Twitch & Kite Pharma Flies

AMC’s "Breaking Bad" was the big winner at the Emmy’s this week, taking home the award for best drama series.

08/28/14 - 08:00 PM EDT

Exelixis Drug Fails Pivotal Prostate Cancer Study

Exelixis Drug Fails Pivotal Prostate Cancer Study

As a result of the negative prostate cancer study, Exelixis intends to downsize by firing 70% of its workforce.

09/02/14 - 09:33 AM EDT

Why GlaxoSmithKline (GSK) Stock Is Gaining Today

Why GlaxoSmithKline (GSK) Stock Is Gaining Today

  • Tickers in this article:
  • GSK

GlaxoSmithKline (GSK) shares are rising following reports that the company is set to begin human trials for an Ebola vaccine in the coming weeks.

08/28/14 - 10:32 AM EDT

Teva Dividend Could Be Hurt by Bank of Israel’s Rate Cut

Teva Dividend Could Be Hurt by Bank of Israel’s Rate Cut

Bank of Israel reduced its cash rate to a historic low of 0.25%. This decision could have an adverse impact on the dividend payment of Teva Pharmaceutical Industries.

08/28/14 - 06:00 AM EDT

Why Lannett (LCI) Stock Is Gaining In After-Hours Trading Today

Why Lannett (LCI) Stock Is Gaining In After-Hours Trading Today

  • Tickers in this article:
  • LCI

Lannett (LCI) shares are up in after-hours trading after reporting a 100% jump in quarterly net sales.

08/27/14 - 05:00 PM EDT

Why Galena Biopharma (GALE) Stock Is Spiking Today

Why Galena Biopharma (GALE) Stock Is Spiking Today

  • Tickers in this article:
  • GALE

Galena Biopharma (GALE) shares are up double digits after analysts at MLV & Co reiterated their 'buy' rating on the stock.

08/27/14 - 11:36 AM EDT

Why Alcobra (ADHD) Stock Is Declining Today

Why Alcobra (ADHD) Stock Is Declining Today

  • Tickers in this article:
  • ADHD

Alcobra (ADHD) shares are falling after analysts at FBR Capital initiated coverage with a 'market perform' rating on Wednesday.

08/27/14 - 09:58 AM EDT

Previewing Tetraphase Oral Antibiotic Study Results

Previewing Tetraphase Oral Antibiotic Study Results

  • Tickers in this article:
  • TTPH

Tetraphase will report data from a phase III study of eravacycline in which the experimental antibiotic is first given by intravenous infusion and then transitioned to an oral form.

08/27/14 - 08:00 AM EDT

Why Merck (MRK) Stock Is Gaining Today

Why Merck (MRK) Stock Is Gaining Today

  • Tickers in this article:
  • MRK

Merck (MRK) shares are climbing after the company revealed a collaborative effort with Pfizer on lung cancer treatment trials.

08/26/14 - 03:14 PM EDT

Your September Biotech Back-to-School Calendar

Your September Biotech Back-to-School Calendar

The biotech sector hews close to an academic calendar and September marks the start of the busy, event-filled push into the end of the year.

08/26/14 - 09:50 AM EDT

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
DOW 17,075.94 -22.51 -0.13%
S&P 500 2,002.27 -1.10 -0.05%
NASDAQ 4,590.2930 +10.0220 0.22%

Brokerage Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs